AVITA Medical to Announce Second Quarter 2024 Financial Results
11. Juli 2024 16:10 ET
|
AVITA Medical
AVITA Medical will report its second quarter 2024 financial results after market close on August 8 2024 and host a webcast that day at 1:30 PM PDT.
AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary
01. Juli 2024 16:05 ET
|
AVITA Medical
AVITA Medical appoints Nicole Kelsey as Chief Legal and Compliance Officer and Corporate Secretary, succeeding Donna Shiroma who is retiring as GC.
AVITA Medical Achieves Milestone with First Case Using RECELL GO
05. Juni 2024 16:25 ET
|
AVITA Medical
Joseph M. Still Burn Center at Doctors Hospital of Augusta treats first patient using AVITA Medical’s FDA-Approved RECELL GO System.
AVITA Medical Announces FDA Approval of RECELL GO
30. Mai 2024 09:15 ET
|
AVITA Medical
AVITA Medical receives FDA approval for RECELL GO, its next-generation device used to treat thermal burn wounds and full thickness skin defects.
AVITA Medical to Host Investor Webinar Briefing
16. Mai 2024 18:30 ET
|
AVITA Medical
AVITA Medical to host investor webinar briefing and presentation on May 21, 2024, at 4:00 p.m. Pacific Daylight Time.
AVITA Medical Reports First Quarter Financial Results
13. Mai 2024 16:01 ET
|
AVITA Medical
AVITA Medical (NASDAQ: RCEL, ASX: AVH) today reported financial results for the first quarter ended March 31, 2024.
AVITA Medical to Announce First Quarter 2024 Financial Results
15. April 2024 17:05 ET
|
AVITA Medical
AVITA Medical will report first quarter 2024 financial results after the close on May 13, 2024, and host a webcast that day at 1:30 p.m. Pacific Time.
AVITA Medical Updates Expected First Quarter 2024 Revenue
10. April 2024 17:11 ET
|
AVITA Medical
AVITA Medical updates expected Q1 2024 commercial revenue; reaffirms expectations for full-year 2024 revenue at lower end of previously provided guidance.
AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement
29. Februar 2024 16:02 ET
|
AVITA Medical
AVITA Medical submitted its response to FDA for additional information in connection to RECELL GO PMA supplement. Submission resumes substantive review.
AVITA Medical to Present at TD Cowen 44th Annual Health Care Conference
29. Februar 2024 09:00 ET
|
AVITA Medical
AVITA Medical to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024, at 9:50 a.m. Eastern Time.